Trial intelligence / Profile preview

N-acetylcysteine in liver preservation solution during liver transplantation

2011-000030-11Phase 3Completed

Sponsor
Health Research Institute Hospital La Fe
Start
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of acetylcysteine in hepatic disease (2 arms), sponsored by Health Research Institute Hospital La Fe. Primary endpoints: Total bilirubin, Primary graft dysfunction and 6 more. Started Jan 2011; status: completed.

02

Drugs

acetylcysteine
03

Conditions

hepatic disease

Beyond the preview

Go deeper on 2011-000030-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000030-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call